MedTrace Logo

INAS-FOCUS (International Active Surveillance Study - Folate in Oral Contraceptives Utilization Study)

NCT01266408 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 82921

Last updated 2020-07-28

No results posted yet for this study

Summary

The study compares the risks of short- and long-term use of contraceptives containing drospirenone (DRSP) or dienogest (DNG)/ethinylestradiol (EE) plus levomefolate calcium (metafolin) with the risks of short- and long-term use of other established oral contraceptives (OCs).

Conditions

  • Contraception

Sponsors & Collaborators

  • Bayer

    collaborator INDUSTRY

  • Center for Epidemiology and Health Research, Germany

    lead OTHER

Principal Investigators

  • Juergen C Dinger, PhD, MD · Center for Epidemiology and Health Research

Eligibility

Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-11-22
Primary Completion
2019-09-29
Completion
2019-10-02

Countries

  • Germany

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01266408 on ClinicalTrials.gov